1983Journal of Cerebral Blood Flow & MetabolismOpen access

Role of Prostaglandins in the Response of the Cerebral Circulation to Carbon Dioxide in Conscious Rabbits

David W. Busija

Open full text 28 citations

Abstract

The role of prostaglandins in maintenance of resting cerebral blood flow (CBF) and in cerebral vasodilatation during hypercapnia remains controversial. The effect of indomethacin, a cyclo-oxygenase inhibitor, on CBF and cerebrovascular resistance (CVR) was examined in conscious animals. Regional and total CBF were measured with radioactive microspheres, and the efficacy of blockade of prostaglandin synthesis by indomethacin was examined by the cranial window method. CBF was measured in conscious rabbits with 15-μm radioactive microspheres during normocapnia (Pco 2 ≈ 30 mm Hg) and hypercapnia (Pco 2 ≈ 60 mm Hg), before and after intravenous administration of indomethacin (10 mg/kg) or vehicle (n = 6 for each). Thus, each animal served as its own control. CBF was 84 ± 6 and 190 ± 27 (mean ± SE) ml/min/100 g during normocapnia and hypercapnia, respectively, before indomethacin, and 78 ± 5 ml/min/100 g during normocapnia and 180 ± 16 ml/min/100 g during hypercapnia following indomethacin. Thus, indomethacin did not change normocapnic CBF. In addition, cerebrovascular responses during hypercapnia did not vary between the indomethacin and vehicle groups. Indomethacin did not attenuate increases in blood flow in any area of the brain, except slightly to cerebellum during hypercapnia. Indomethacin did not affect CVR during normocapnia or hypercapnia. The topical application of arachidonic acid (75 and 150 μg/mg), dissolved in cerebrospinal fluid, dilated pial arteries in a dose-dependent fashion. Intravenous administration of indomethacin (10 mg/kg) blocked vasodilatation produced by arachidonic acid by 87% (p < 0.05). Thus, indomethacin, at a dose that effectively inhibits prostaglandin synthesis, did not change resting CBF or CVR or attenuate the increase in CBF or decrease in CVR during hypercapnia. These findings suggest that prostaglandins do not contribute significantly to regulation of the cerebral circulation during normocapnia and hypercapnia.

Open-access reader

About this research paper

What this paper is about

The role of prostaglandins in maintenance of resting cerebral blood flow (CBF) and in cerebral vasodilatation during hypercapnia remains controversial. The effect of indomethacin, a cyclo-oxygenase inhibitor, on CBF and cerebrovascular resistance (CVR) was examined in conscious animals. Regional and total CBF were measured with radioactive microspheres, and the efficacy of blockade of prostaglandin synthesis by indomethacin was examined by the cranial window method. CBF was measured in conscious rabbits with 15-μm radioactive microspheres during normocapnia (Pco 2 ≈ 30 mm Hg) and hypercapnia (Pco 2 ≈ 60 mm Hg), before and after intravenous administration of indomethacin (10 mg/kg) or vehicle (n = 6 for each). Thus, each animal served as its own control. CBF was 84 ± 6 and 190 ± 27 (mean ± SE) ml/min/100 g during normocapnia and hypercapnia, respectively, before indomethacin, and 78 ± 5 ml/min/100 g during normocapnia and 180 ± 16 ml/min/100 g during hypercapnia following indomethacin. Thus, indomethacin did not change normocapnic CBF. In addition, cerebrovascular responses during hypercapnia did not vary between the indomethacin and vehicle groups. Indomethacin did not attenuate increases in blood flow in any area of the brain, except slightly to cerebellum during hypercapnia. Indomethacin did not affect CVR during normocapnia or hypercapnia. The topical application of arachidonic acid (75 and 150 μg/mg), dissolved in cerebrospinal fluid, dilated pial arteries in a dose-dependent fashion. Intravenous administration of indomethacin (10 mg/kg) blocked vasodilatation produced by arachidonic acid by 87% (p < 0.05). Thus, indomethacin, at a dose that effectively inhibits prostaglandin synthesis, did not change resting CBF or CVR or attenuate the increase in CBF or decrease in CVR during hypercapnia. These findings suggest that prostaglandins do not contribute significantly to regulation of the cerebral circulation during normocapnia and hypercapnia.

Why it matters

OpenAlex reports 28 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The role of prostaglandins in maintenance of resting cerebral blood flow (CBF) and in cerebral vasodilatation during hypercapnia remains controversial. The effect of indomethacin, a cyclo-oxygenase inhibitor, on CBF and cerebrovascular resistance (CVR) was examined in conscious animals. Regional and total CBF were measured with radioactive microspheres, and the efficacy of blockade of prostaglandin synthesis by indomethacin was examined by the cranial window method. CBF was measured in conscious rabbits with 15-μm radioactive microspheres during normocapnia (Pco 2 ≈ 30 mm Hg) and hypercapnia (Pco 2 ≈ 60 mm Hg), before and after intravenous administration of indomethacin (10 mg/kg) or vehicle (n = 6 for each). Thus, each animal served as its own control. CBF was 84 ± 6 and 190 ± 27 (mean ± SE) ml/min/100 g during normocapnia and hypercapnia, respectively, before indomethacin, and 78 ± 5 ml/min/100 g during normocapnia and 180 ± 16 ml/min/100 g during hypercapnia following indomethacin. Thus, indomethacin did not change normocapnic CBF. In addition, cerebrovascular responses during hypercapnia did not vary between the indomethacin and vehicle groups. Indomethacin did not attenuate increases in blood flow in any area of the brain, except slightly to cerebellum during hypercapnia. Indomethacin did not affect CVR during normocapnia or hypercapnia. The topical application of arachidonic acid (75 and 150 μg/mg), dissolved in cerebrospinal fluid, dilated pial arteries in a dose-dependent fashion. Intravenous administration of indomethacin (10 mg/kg) blocked vasodilatation produced by arachidonic acid by 87% (p < 0.05). Thus, indomethacin, at a dose that effectively inhibits prostaglandin synthesis, did not change resting CBF or CVR or attenuate the increase in CBF or decrease in CVR during hypercapnia. These findings suggest that prostaglandins do not contribute significantly to regulation of the cerebral circulation during normocapnia and hypercapnia.

Key concepts: Normocapnia, Hypercapnia, Cerebral blood flow, Vasodilation, Anesthesia, Chemistry, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Role of Prostaglandins in the Response of the Cerebral Circulation to Carbon Dioxide in Conscious Rabbits — Research Paper | ScholarLens